Skip to content

Public FDA record

Z-1242-2019: FilmArray Gastrointestinal (GI) Panel, IVD, Rx Only, Biofire Diagnostics, LLC REF: RFIT-ASY-0104, and RF

Recall record Z-1242-2019 for BioFire Diagnostics, LLC. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1242-2019
Company in FDA record
BioFire Diagnostics, LLC
FDA record creation date
Apr 27, 2019
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Elevated rates of false positive results for Campylobacter and Cryptosporidium have been identified.

Source facts

Action
On 03/05/19, Urgent Medical Device Recall (Correction) notices were mailed to customers. Customers were advised, that if they used affected devices, positive Campylobacter and Cryptosporidium results should be confirmed by another method prior to reporting the test results. The firm advised customers that the issue was currently under investigation and they would notify customers if additional pertinent information was uncovered. Customers that further distributed product were asked to notify their customers at once of this product recall. As of 02/26/19, the firm temporarily stopped shipment of affected devices. Customers were asked to complete and return the Acknowledgment of Receipt Form. The following contact information was on the safety notice: 1-800-735-6544 and 801-736-6354. On 03/13/19, Urgent Medical Device Recall (Correction) notices were mailed to customers. Customers were advised that this was an expansion/revision of the previous notice) to include newly manufactured GI panel kit lots and to provide revised recommended actions for use of the affected product. Firm resumed shipment of the product with the following limitations: Limitations: - Users may experience combined rates of false positive Campylobacter and Cryptosporidium results ranging from 0 - 9% while using the GI Panel. The majority of product is expected to exhibit rates below 3%. - For specimens that test positive for Campylobacter and/or Cryptosporidium on the GI Panel: Results should be confirmed by retesting using a new GI Panel pouch or by an alternative assay for Campylobacter and/or Cryptosporidium. Only results from confirmatory retesting for Campylobacter and/or Cryptosporidium should be reported for that analyte. - If confirmatory testing is performed with the GI Panel overall specificity is estimated to be (>99%) of both of these analytes, but may also result in a small reduction in sensitivity (by approximately 2-2.5%; from 97.1% to 94.7% for Campylobacter and
Initiated
2019-03-06
Root cause
Device Design
Terminated
2022-02-18
Distribution
Worldwide Distribution - US Nationwide in the states of: CO, IL, NJ, PA, OH, FL, KY, NE, NY, CA, WV, UT, TX, MS, OK, WI, NC, DE, IN, MN, AK, ND, GA, AR, MO, KS, HI, IA, LA, VA, SC, MT, NM, SD, AL, WY, AZ, WA, TN, OR, MI, MA, NV, MD, CT, DC, VT, ID, NH, RI, ME. Foreign (OUS): Argentina, Austria, Australia, Belgium, Brazil, Canada, Switzerland, Ivory Coast, Chile, Colombia, Czech Republic, Germany, Spain, France, United Kingdom, Greece, Hong Kong, Hungary, India, Italy, Japan, South Korea, Mexico, Netherlands, Poland, Portugal, Sweden, Singapore, Thailand, Turkey, South Africa, Utd.Arab Emir., Puerto Rico,Dutch Antilles,Angola, Bangladesh, Burkina Faso, Bulgaria, Bahrain, Bermuda, Botswana, Dem. Rep. Congo, Costa Rica, Dominican Rep., Algeria, Ecuador, Estonia, Egypt, Gabon, Georgia, Guatemala, Guam, Croatia, Haiti, Israel, Iraq, Jordan, Kenya, Kuwait, Lebanon, Morocco, Macedonia, Malta, Malaysia, Nicaragua, Oman, Panama, Peru, Philippines, Pakistan, Qatar, Romania, Serbia, Saudi Arabia, Slovenia, El Salvador, Uruguay, Vietnam, Denmark, Slovakia
Recall number
Z-1242-2019
Recall status
Terminated
CDRH record ID
171388
FDA record created
2019-04-27
Recall event number
82338

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗